EGFR and breast carcinoma: In response to EGF stimulation, the EGFR controls expression of hexokinase (HK1) and phosphorylation of the pyruvate kinase M2 (PKM2), two glycolytic enzymes that catalyze key steps in the pathway, thus increasing aerobic glycolysis of breast cancer cells (Lim et al., 2016).